Signaling by the angiotensin-converting enzyme

Circulation Research
I Fleming

Abstract

Inhibition of the angiotensin-converting enzyme (ACE) protects against the progression of several cardiovascular diseases. Because of its dual role in regulating angiotensin II and bradykinin levels, the positive clinical effects of ACE inhibitors were thought to be the consequence of concomitant reductions in the production of angiotensin II and the degradation of bradykinin. Recent evidence suggests that some of the beneficial effects of ACE inhibitors on cardiovascular function and homeostasis can be attributed to novel mechanisms. These include the accumulation of the ACE substrate N-acetyl-seryl-aspartyl-lysyl-proline, which blocks collagen deposition in the injured heart, as well as the activation of an ACE signaling cascade that involves the activation of the kinase CK2 and the c-Jun N-terminal kinase in endothelial cells and leads to changes in gene expression. Moreover, at least one other ACE homologue (ACE2) is proposed to counteract the detrimental effects associated with the activation of the classical renin-angiotensin system. These data reveal hitherto unexpected levels of internal regulation of the renin-angiotensin system.

References

Aug 21, 1970·Biochimica Et Biophysica Acta·H Y YangY Levin
Jul 1, 1995·The American Journal of Physiology·I F BenterD I Diz
Apr 15, 2000·Journal of Molecular Biology·G D BrenC V Paya
May 26, 2001·Science·N IwataT C Saido
Oct 26, 2001·JAMA : the Journal of the American Medical Association·S YusufUNKNOWN HOPE Study Investigators
May 11, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Chih-Chang WeiLouis J Dell'Italia
Sep 5, 2002·British Journal of Pharmacology·Beril TomA H Jan Danser
Oct 9, 2002·Mini Reviews in Medicinal Chemistry·Ramón Cacabelos
Dec 5, 2002·The Journal of Biological Chemistry·Elizabeth A EckmanChristopher B Eckman
Dec 25, 2002·Trends in Pharmacological Sciences·Rudi Busse, Ingrid Fleming
Jan 24, 2003·Nature·Ramanathan NateshK Ravi Acharya
Apr 18, 2003·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Ursula DanilczykJosef M Penninger
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Robson A S SantosThomas Walther
Sep 26, 2003·Zeitschrift für Kardiologie·C Stöllberger, J Finsterer
Oct 29, 2003·Hypertension·Hongmei PengNour-Eddine Rhaleb
Nov 15, 2003·Circulation Research·Karin KohlstedtIngrid Fleming
Mar 11, 2004·Current Hypertension Reports·Sebastien FuchsKenneth E Bernstein

❮ Previous
Next ❯

Citations

May 30, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Friedrich C Luft
Jan 10, 2013·Archives of Dermatological Research·Christos YapijakisEleftherios Vairaktaris
May 27, 2011·Age·Matea Zajc PetranovićSpomenka Tomek-Roksandić
Sep 9, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Jun-Ren ZhuUNKNOWN trial investigators
Oct 22, 2011·Clinical and Experimental Pharmacology & Physiology·Shan LiuHenry Krum
Mar 6, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Vijaykumar S KasiSamuel C Dudley
Aug 7, 2012·Cancer Research·Vijayalakshmi SridharanMarjan Boerma
Nov 19, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kazuto NakamuraMasataka Sata
Dec 25, 2009·Biological Chemistry·Xiaoou SunWolf-Eberhard Siems
Jun 1, 2007·Biomarkers in Medicine·Ulf AndreassonHenrik Zetterberg
Feb 21, 2014·Journal of Pharmacology & Pharmacotherapeutics·Turhan DostMustafa Birincioglu
Jul 3, 2010·EMBO Molecular Medicine·Ariela BenigniGiuseppe Remuzzi
Jul 9, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Aline Mourao HilzendegerJoão Bosco Pesquero
Aug 21, 2013·Expert Opinion on Therapeutic Targets·Nelly Blaes, Jean-Pierre Girolami
Oct 5, 2010·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Sergei I MalekinSergei N Orlov
Aug 10, 2010·Regulatory Peptides·Gorka LarrinagaAdolfo Varona
Dec 5, 2009·European Journal of Pharmacology·Sofia V ChatzikyriakouHarisios Boudoulas
Feb 5, 2010·The American Journal of Cardiology·Jeffrey L Probstfield, Kevin D O'Brien
Aug 5, 2008·Vascular Pharmacology·P D'Orléans-JusteE Simard
Jan 19, 2008·Peptides·Guillaume MorissetteFrançois Marceau
Nov 28, 2006·Pharmacology & Therapeutics·Cristina OroWalter G Thomas
Jan 12, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·E EmanueleD Geroldi
Sep 29, 2011·CNS Neuroscience & Therapeutics·Jian-Guang YuGuo-Jun Cai
Nov 23, 2010·Journal of Clinical Laboratory Analysis·Ioannis PanagiotopoulosElli F Kamper
Jun 2, 2015·Canadian Journal of Physiology and Pharmacology·Jan SlezakMiroslav Barancik
Jan 26, 2010·Chemico-biological Interactions·Carlos R OliveiraClaudia Bincoletto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.